Beijing Tiantan Biological Products (SHA:600161) obtained official licenses from the Gansu Provincial Health Commission for four plasma collection stations under its Lanzhou subsidiary.
The newly approved stations, Gaolan, Yongdeng, Gangu, and Jinta, are now permitted to begin operations, according to a Tuesday filing with the Shanghai bourse.
Shares of the blood products manufacturer rose nearly 4% in recent trade.